{
    "symbol": "CARA",
    "quarter": 1,
    "year": 2022,
    "date": "2022-05-09 18:20:02",
    "content": "  Examples of these forward-looking statements, include statements concerning the company's ability to successfully commercialize KORSUVA injection, including the timing of the product launch; planned future regulatory submissions; and potential future regulatory approvals; the company's ability to maintain coverage and adequate reimbursement of KORSUVA injection; the performance of our commercial partners including Vifor Pharma; expected timing of the initiation, enrollment and data readouts from the company's planned and ongoing clinical trials; the potential results of ongoing clinical trials, timing of future regulatory and development milestones for the company's products candidates; the potential for the company's products candidates to be alternatives in therapeutic areas investigated; despite and growth of the potential markets for current management; the company's expected cash reach and the potential impact of COVID-19 on the company's commercial launch, clinical development, and regulatory timelines and plans. Your line is open. Your line is open. Your line is open. Your line is open. Your line is open. Your line is open."
}